What an oncologist’s report must establish to support a material contribution argument in delayed cancer diagnosis claims

The role of oncological evidence in material contribution arguments

In clinical negligence litigation concerning delayed cancer diagnosis, claimants may seek to establish that the delay resulted in a less favourable outcome. Where the causal link between the delay and a specific clinical deterioration cannot be proven on the balance of probabilities under the ‘but-for’ test, the legal concept of material contribution may be invoked. An oncologist’s report serves as the primary instrument for assessing whether the delayed intervention made a real, rather than speculative, contribution to disease progression or reduced prospects of long-term survival.

Key elements of oncologist evidence

An expert report must distinguish between the natural history of the disease and the specific impact of the identified delay. To support a material contribution argument, the oncologist should address relevant clinical factors, such as:

• The tumour’s growth rate, where evidence permits;
• Histopathological features, including grade and receptor status;
• The extent of disease spread at the time diagnosis should have occurred, compared with the actual diagnosis date.

The opinion should focus on whether, during the period of delay, the tumour reached a stage that materially reduced the efficacy of treatment or rendered previously curative options less effective. The expert may define a ‘critical window’ for intervention and explain how the failure to act within that timeframe exacerbated the claimant’s condition, provided the clinical evidence supports such a conclusion.

The evidential foundation for causation

The strength of a material contribution argument depends on the availability and completeness of clinical evidence. A primary challenge involves comparing initial radiological or histopathological findings with those identified at the point of confirmed diagnosis. Where primary imaging is unavailable, the expert must acknowledge the uncertainty regarding tumour size or stage at the earlier time point.

• Histopathology reports: Confirm tumour type, grade, and staging.
• Radiological imaging: Used to assess tumour volume and pattern of metastasis, where available.
• Clinical records: Establish the timing of symptoms that should have triggered a referral or diagnostic test.
• Multidisciplinary team (MDT) notes: Provide context on the decision-making process at the time of eventual diagnosis.

Where records are incomplete, the expert cannot reasonably determine the tumour’s growth rate or the likely efficacy of treatment at the earlier date, which may weaken the claim.

Distinguishing breach of duty from causation

The assessment of breach of duty rests on the Bolam standard, as qualified by Bolitho. The expert determines whether the diagnostic failure or delay in referral fell below the standard of a responsible body of relevant clinicians at the time. The expert must assess the decision-making process without the benefit of hindsight. Once a breach is established, the focus shifts to causation.

In England and Wales, the claimant must typically prove that the negligence caused the loss on the balance of probabilities. Material contribution is an exceptional legal concept applied where the claimant can demonstrate that the breach was a cause of the injury, even if it is not possible to prove that the outcome would have been definitively different had the breach not occurred. The oncologist’s report must provide the clinical basis for this contribution by demonstrating that the delay allowed for physiological progression that significantly impacted the patient’s prognosis.

Discipline boundaries and expert collaboration

Oncological evidence rarely stands in isolation. A claim involving delayed diagnosis may require input from a primary care physician, radiologist, or specialist surgeon, depending on the tumour site. The oncologist’s report must remain within the boundaries of their expertise. For example, while an oncologist can comment on the clinical significance of a missed radiological finding, they should not opine on whether the initial radiological report fell below the standard of a competent radiologist. Instructing solicitors should ensure that the report clearly delegates the interpretation of imaging to a consultant radiologist, thereby preserving the clarity and authority of the expert evidence. For further context on providing evidence on delayed diagnosis, expert collaboration is often essential.

Procedural requirements under CPR Part 35

The expert’s overriding duty to the court, as set out in CPR 35.3, demands absolute objectivity. When preparing an opinion on material contribution, the expert must clarify whether the delay had no clinical impact or significantly compromised the outcome. The report must comply with CPR 35.10, which requires a statement of the expert’s qualifications, the substance of all instructions, and the facts and assumptions relied upon.

Where appropriate, experts may be directed by the court or agree to participate in discussions under CPR 35.12 to produce a joint statement. These discussions aim to narrow the issues and identify areas of agreement and disagreement. A report that effectively supports a material contribution argument provides a transparent explanation of the biological and clinical data, acknowledging the limits of medical certainty. The legal team can then assess the viability of the claim based on the demonstrable clinical impact of the delay.

A well-prepared oncologist’s report also facilitates the assessment of quantum by addressing both the current condition and the predicted trajectory of the cancer. Where the prognosis remains uncertain, the report must reflect this, noting whether further review of clinical developments is necessary.